Ladenburg Thalmann Financial Services’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$11K Hold
2,200
﹤0.01% 4451
2019
Q3
$3K Hold
2,200
﹤0.01% 4880
2019
Q2
$3K Hold
2,200
﹤0.01% 4895
2019
Q1
$3K Sell
2,200
-6,000
-73% -$6.88K ﹤0.01% 4849
2018
Q4
$7K Buy
8,200
+8,000
+4,000% +$9.2K ﹤0.01% 4462
2018
Q3
$0 Buy
+200
New +$304 ﹤0.01% 5285
2017
Q1
Sell
-175
Closed -$1K 4944
2016
Q4
$1K Buy
+175
New +$812 ﹤0.01% 4695
2013
Q4
Sell
-286
Closed -$5K 3830
2013
Q3
$5K Sell
286
-142
-33% -$2.48K ﹤0.01% 3195
2013
Q2
$7K Buy
+428
New +$9.05K ﹤0.01% 2905

Other funds holding FLNA

Ladenburg Thalmann Financial Services's FLNA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Filana Therapeutics (FLNA) position steady in Q4 2019 at 2,200 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Ladenburg Thalmann Financial Services first reported a position in FLNA in Q2 2013 and has held it in 9 quarters since. 31 funds tracked by Wall St. Rank hold FLNA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,200 shares of Filana Therapeutics worth $11K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Filana Therapeutics share count unchanged in Q4 2019.
  • Filana Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4451 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Filana Therapeutics in Q2 2013 and has held it in 9 quarters since.
  • 31 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.